We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Overactive Brain Circuit Faulted for Depression

By Biotechdaily staff writers
Posted on 10 Aug 2004
A brain imaging study has found that an emotion-regulating brain circuit is overactive in people who are prone to depression. The finding was reported in the August 2004 issue of Archives of General Psychiatry.

Researchers discovered the abnormality in brains of those whose depressions relapsed when a key brain chemical messenger was experimentally reduced. Even when in remission, most subjects with a history of mood disorder experienced a temporary recurrence of symptoms when their brains were experimentally sapped of tryptophan, the chemical precursor of serotonin, the neurotransmitter boosted by antidepressant medications.

Neither a placebo procedure in patients nor tryptophan depletion in healthy volunteers triggered the mood and brain activity changes. The scans revealed that a key motion-processing circuit was overactive only in patients in remission--whether or not they had re-experienced symptoms--and not in controls. Since the abnormal activity did not reflect mood state, the finding suggests that tryptophan depletion unmasks an inborn trait associated with depression.

The researchers scanned subjects with positron emission tomography (PET) after their blood tryptophan levels were reduced by about three-fourths, using a radioactive tracer that reveals where the brain is active during a particular experimental condition. Pills containing seven essential amino acids or identical-looking placebo pills were given randomly to 27 unmedicated depressed patients in remission and 19 controls. Sixteen patients experienced a transient return of symptoms under tryptophan depletion, but their mood lifted to normal by the next day. Compared to controls, the patients showed increased brain activity in areas involved in regulating emotions.

"Since brain function appears to be disregulated even when patients are in remission, they need to continue long-term treatment beyond the symptomatic phase of their illness,” noted Dr. Alexander Neumeister, one of the authors of the study, conducted by the U.S. National Institute of Mental Health (Bethesda, MD, USA).




Related Links:
NIMH

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Automatic CLIA Analyzer
Shine i6000
New
Electrolyte Analyzer
BKE-B

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
10 Aug 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
10 Aug 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
10 Aug 2004  |   BioResearch